Instructions for Clenbuterol syrup bottle 100 ml
English product name
Clenbuterol
Release form
Sirop
Description:
Syrup in the form of a clear, colourless liquid with a characteristic raspberry smell.
1 ml
- Clenbuterol hydrochloride 1 ug
- Auxiliary substances: sorbitol - 280 mg,
- glycerol - 200 mg,
- propylene glycol - 100 mg,
- sodium citrate dihydrate - 5.8 mg,
- citric acid monohydrate - 7 mg,
- methylparahydroxybenzoate - 0.45 mg,
- propyl parahydroxybenzoate - 0.05 mg,
- butylparahydroxybenzoate - 0.05 mg,
- sodium benzoate - 1.2 mg,
- raspberry essence - 0.45 mg,
- ethanol 96% - 5 mg,
- water purified - up to 1 ml.
100 ml - dark glass bottles (1) complete with measuring spoon - cardboard packs.
ATC codes
R03CC13 Clenbuterol
Clinical-pharmacological groups / Group affiliation
Broncholytic preparation - beta<SUB>2</SUB>-adrenomimetic
Active substance
Clenbuterol hydrochloride
Pharmacotherapeutic group:
Beta2-adrenomimetic selective
Storage Conditions
At temperatures not exceeding 25°C. Keep away from children!
Best before date
Shelf life - 3 years.
Testimony:
bronchial asthma;
chronic obstructive pulmonary disease (COPD).
Method of use, course and dosage:
The drug is taken in.
Daily dose for children from 6 to 12 years (body weight 22-35 kg) - 15 mcg (for 2 doses).
Adults and children over the age of 12: 2 times a day for 10-20 micrograms.
The maintenance dose is 2 times 10 micrograms.
The duration of treatment with the drug Clenbuterol is 2-3 days, until the acute symptoms of the disease are removed.
Duration of maintenance therapy should not exceed 7 days. The decision on treatment for a period exceeding the seven-day period is made by the doctor.
Application for kidney disorders
With care for kidney failure.
Application for liver function disorders
With caution in liver failure.
Terms of Sale
On prescription.
Use in children
Contraindicated to children under 6 years.
- Nosology (ICD codes)
- J44
- Other chronic obstructive pulmonary disease
- J45
- Asthma
Pharmacological effect:
is one of the group of selective β2-adrenomimetics. is a drug that has a rapid broncholytic effect. Its action is caused by specific stimulation of β2 - adrenoreceptors of smooth muscle. By binding to them, adenylate cyclase is activated, leading to increased intracellular concentration of cyclic adenosine monophosphate and activation of proteinkinase A, and depriving myosin of its ability to bind to actin, resulting in bronchial relaxation. Clenbuterol stimulates cells in the mucous membrane of the bronchi and enhances thinning. In prescribed therapeutic doses, clenbuterol does not affect heart rate or blood pressure.
